Exhibiting at VIV Asia 2025

TECNOVAX S.A., headquartered in Victoria, Argentina, is a leading biotechnology company specializing in the development, manufacturing, and commercialization of high-quality vaccines and biological products for animal health. Established in 1991, the company has built a strong reputation for its expertise in providing innovative solutions to prevent and control infectious diseases in various animal species.

Core Business

TECNOVAX S.A. focuses on research, development, manufacturing, and distribution of veterinary biological products that cater to the needs of the livestock, companion animal, and aquaculture industries. The company's state-of-the-art production facilities and commitment to research excellence have positioned it as a trusted supplier of vaccines and biological solutions in the global market.

Product and Service Offerings

TECNOVAX S.A. offers a diverse range of vaccines and biological products categorized by animal species:

• Ruminants (Cattle, Sheep, Goats):

  • RESPI 8 QUERATO: Bovine respiratory disease complex vaccine.
  • REPRO 12: Reproductive vaccine designed to improve fertility and protect against reproductive diseases.
  • ENTERO PLUS 7: Broad-spectrum vaccine for enterotoxemia and other clostridial infections.
  • CLOSTRIDIAL 10P: Vaccine targeting various clostridial diseases.
  • BH-RAB: Bovine rabies vaccine.
  • BRUCELOSIS: Vaccine for the prevention of Brucellosis in cattle.

• Equines (Horses):

  • Contendor Encefalo: Encephalomyelitis and influenza vaccine for horses.
  • Contendor 2: Comprehensive equine vaccine targeting respiratory and neurological diseases.
  • Contendor 5: Multi-valent vaccine designed for broader protection against equine diseases.

• Canines and Felines (Dogs and Cats):

  • VIRATEC 10 CV 4L: Multi-component vaccine for protecting dogs against various viral infections.
  • VIRATEC 9 (4L): Canine vaccine with broad-spectrum protection.
  • VIRATEC 6 CV: Vaccine for the prevention of canine distemper, hepatitis, and parvovirus.
  • VIRATEC 5: Core vaccine providing essential protection for canines.
  • VIRATEC DP: Bivalent vaccine for canine distemper and parvovirus.
  • BH-PUR: Vaccine designed to enhance immunity in companion animals.

• Aquatic Animals (Fish, Shrimp):

  • AQUATEC SEA LICE: Specialized vaccine for controlling sea lice in aquaculture.
  • AQUATEC 1 to 5: Series of vaccines aimed at preventing various bacterial and viral infections in aquatic species.

Specialization and Core USP

TECNOVAX S.A.'s Unique Selling Proposition (USP) is its commitment to biotechnological innovation and the production of highly effective vaccines tailored to meet the specific needs of each animal species. The company’s extensive product range demonstrates its ability to address critical health challenges faced by livestock, companion animals, and aquaculture industries worldwide. Its proprietary brands Providean, Contendor, Viratec, and Aquatec are well-known in the market for their reliability and efficacy.

Financials and Market Presence

TECNOVAX S.A. has established a strong market presence in Latin America, Europe, Asia, and Africa, with consistent growth in revenue driven by the increasing demand for high-quality animal vaccines. The company's export capabilities have significantly contributed to its financial performance, highlighting its success in catering to various international markets.

Shipments Data

The company's shipment data reflects robust performance across various markets, with high demand for its Viratec and Aquatec product lines. TECNOVAX S.A. continues to expand its distribution network to meet the growing needs of veterinary and aquaculture industries globally.

Target Market

TECNOVAX S.A. primarily targets:

• Livestock Producers (Cattle, Sheep, Goats): Offering vaccines that address respiratory, reproductive, and clostridial diseases.
• Equine Owners and Breeders: Providing specialized vaccines to protect horses from infectious diseases.
• Pet Owners and Veterinary Clinics: Supplying multi-component vaccines designed for comprehensive protection against viral and bacterial infections.
• Aquaculture Operations (Fish and Shrimp): Delivering innovative vaccines aimed at preventing bacterial, viral, and parasitic infections to enhance production efficiency.

Capabilities

TECNOVAX S.A. possesses cutting-edge research and manufacturing capabilities, including:

• Advanced production facilities compliant with Good Manufacturing Practices (GMP) standards.
• A dedicated R&D team focused on developing new vaccines and improving existing formulations.
• Extensive distribution channels covering various regions worldwide.

Certifications and Compliance Records

TECNOVAX S.A. adheres to international quality standards and regulatory requirements, ensuring the safety, efficacy, and consistency of its products. The company's manufacturing facilities are GMP-certified, reflecting its commitment to maintaining high-quality standards in vaccine production.

Customer Testimonials

While specific testimonials are not provided, TECNOVAX S.A.'s strong reputation within the industry is supported by its continued expansion into new markets and its ability to provide reliable and effective biological solutions. Its success in catering to the needs of diverse animal industries demonstrates the company’s ability to deliver high-quality products.

Major Achievements

TECNOVAX S.A. has achieved several milestones over the years, including:

• Launching a diverse portfolio of vaccines targeting various animal species, including livestock, pets, and aquatic animals.
• Establishing successful brands such as Providean, Contendor, Viratec, and Aquatec.
• Expanding its market presence to over 40 countries, with a strong emphasis on Latin America, Europe, Asia, and Africa.
• Continuously investing in research and development to enhance product efficacy and safety.

TECNOVAX S.A. remains dedicated to providing innovative, effective, and reliable biological solutions that meet the evolving needs of animal health industries worldwide. Its unwavering commitment to quality, research, and customer satisfaction continues to drive its success and expand its global presence.